Controlled delivery of the popular nonsteroidal anti-inflammatory drug, paracetamol, from chitosan-g-polyacrylamide microspheres prepared by the emulsion crosslinking technique
Source abstract
Abstract
In this paper, chitosan-graft-polyacrylamide (CS-g-PAAm) microspheres as drug delivery matrices of paracetamol were prepared by the emulsion crosslinking technique, using glutaraldehyde (GA) as a crosslinker. Graft copolymer of chitosan with acrylamide was synthesized using cerium (IV) ammonium nitrate (CAN). The microspheres formed had average particle sizes in the range of 78-252 μm. Paracetamol entrapment efficiency was found to vary between 31.89% and 72.61%, as determined by UV spectroscopy. Drug release in acidic and phosphate buffer solutions (pH 1.2 and 7.4) of the CS-g-PAAm microspheres was influenced by formulation factors such as the concentration of CS-g-PAAm, the paracetamol/polymer ratio (w/w), and the amount of crosslinker.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Advanced Drug Delivery Systems · Hydrogels: synthesis, properties, applications · Polymer Surface Interaction Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Chemistry, Science and Arts Faculty, Afyon Kocatepe University, Afyonkarahisar, Turkey
References (44)
Show source-provided references
1. 10.1016/j.ijpharm.2006.05.06110.1016/j.ijpharm.2006.05.061 ↗
2. 10.1002/app.3079810.1002/app.30798 ↗
3. 10.1016/j.carres.2009.01.01110.1016/j.carres.2009.01.011 ↗
4. 10.1016/j.carbpol.2014.01.01810.1016/j.carbpol.2014.01.018 ↗
5. 10.1016/j.carbpol.2010.08.01710.1016/j.carbpol.2010.08.017 ↗
6. 10.1016/j.ijbiomac.2010.05.00310.1016/j.ijbiomac.2010.05.003 ↗
7. 10.1016/j.carbpol.2006.09.02710.1016/j.carbpol.2006.09.027 ↗
8. 10.1016/j.ijbiomac.2011.10.02010.1016/j.ijbiomac.2011.10.020 ↗
9. 10.1016/S1773-2247(14)50127-X10.1016/S1773-2247(14)50127-X ↗
10. 10.1080/00222348.2013.87431010.1080/00222348.2013.874310 ↗
11. Bulut E · Artif Cells Nanomed Biotechnol · 2015
12. 10.1002/jcp.104152022510.1002/jcp.1041520225 ↗
13. 10.1016/j.ijpharm.2005.11.01210.1016/j.ijpharm.2005.11.012 ↗
14. Enriquez GG · J Nanomed Nanotech · 2014 · 5 · 20810.4172/2157-7439.1000208 ↗
15. 10.1016/j.ijpharm.2004.04.01310.1016/j.ijpharm.2004.04.013 ↗
16. 10.1016/0378-5173(94)00368-F10.1016/0378-5173(94)00368-F ↗
17. 10.1016/S0168-3659(03)00011-710.1016/S0168-3659(03)00011-7 ↗
18. 10.1016/j.carbpol.2009.10.03410.1016/j.carbpol.2009.10.034 ↗
19. 10.1016/j.carbpol.2010.12.05410.1016/j.carbpol.2010.12.054 ↗
20. 10.1016/S0008-6215(01)00112-410.1016/S0008-6215(01)00112-4 ↗
21. 10.1016/j.carbpol.2006.06.02110.1016/j.carbpol.2006.06.021 ↗
22. Kim K-H · Polymer (Korea) · 1987 · 11 · 133
23. 10.1002/app.1238610.1002/app.12386 ↗
24. 10.1002/app.1155210.1002/app.11552 ↗
25. 10.1080/0265204050010026110.1080/02652040500100261 ↗
26. 10.1081/DDC-12001671810.1081/DDC-120016718 ↗
27. 10.1080/0265204080189643510.1080/02652040801896435 ↗
28. 10.1016/j.powtec.2015.01.05310.1016/j.powtec.2015.01.053 ↗
29. 10.1016/j.foodchem.2009.11.08510.1016/j.foodchem.2009.11.085 ↗
30. Peppas NA · Pharm Acta Helv · 1985 · 60 · 110
31. 10.1002/app.2518210.1002/app.25182 ↗
32. 10.3109/21691401.2013.79435610.3109/21691401.2013.794356 ↗
33. 10.1002/app.3316910.1002/app.33169 ↗
34. 10.1002/app.2276010.1002/app.22760 ↗
35. 10.1016/j.carbpol.2007.05.03910.1016/j.carbpol.2007.05.039 ↗
36. 10.1016/0168-3659(87)90035-610.1016/0168-3659(87)90035-6 ↗
37. 10.1016/j.carbpol.2006.07.00110.1016/j.carbpol.2006.07.001 ↗
38. 10.1016/j.ijpharm.2003.12.02610.1016/j.ijpharm.2003.12.026 ↗
39. 10.1007/s10924-012-0554-y10.1007/s10924-012-0554-y ↗
40. 10.1002/app.2716810.1002/app.27168 ↗
41. 10.1016/j.etap.2014.07.00110.1016/j.etap.2014.07.001 ↗
42. 10.1002/app.3204710.1002/app.32047 ↗
43. 10.4028/www.scientific.net/AMR.586.16110.4028/www.scientific.net/AMR.586.161 ↗
44. 10.1016/j.carbpol.2014.06.08010.1016/j.carbpol.2014.06.080 ↗